Proliferative and migratory aptitude in pterygium

Histochemistry and Cell Biology

Volumn 134, Issue 5, 2010, Pages 527-535

  Bai, Haiqing ^a,c   Teng, Yufei ^a   Wong, Lee ^b   Jhanji, Vishal ^a   Pang, Chi Pui ^a   Yam, Gary Hin Fai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG EYE HOSPITAL   (Hong Kong)

^c QINGDAO UNIVERSITY   (China)

Author keywords

ABCG2; Matrix metalloproteinases; p63 ; Pterygium

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CELL MARKER; CYTOKERATIN 15; GELATINASE A; GELATINASE B; PROTEIN P63; TRANSCRIPTION FACTOR PAX6;

ADULT; AGED; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLONY FORMATION; CONJUNCTIVA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; STEM CELL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL COUNT; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CONJUNCTIVA; EPITHELIUM, CORNEAL; EYE PROTEINS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; LIMBUS CORNEAE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PAIRED BOX TRANSCRIPTION FACTORS; PTERYGIUM; REPRESSOR PROTEINS;

EID: 78149467462     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-010-0751-5     Document Type: Article

References (23)

1. MT Coroneo N Di Girolamo D Wakefield 1999 The pathogenesis of pterygia Curr Opin Ophthalmol 10 282 288 1:STN:280:DC%2BD3M%2FgtVClsw%3D%3D 10.1097/00055735-199908000-00011 10621537 (Pubitemid 30339430)
2. ET Detorakis DA Spandidos 2009 Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (Review) Int J Mol Med 23 439 447 1:CAS:528:DC%2BD1MXkvVWhs78%3D 10.3892/ijmm-00000149 19288018
3. N Di Girolamo J Chui MT Coroneo D Wakefield 2004 Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases Prog Retin Eye Res 23 195 228 1:CAS:528:DC%2BD2cXjtFOhsLs%3D 10.1016/j.preteyeres. 2004.02.002 15094131 (Pubitemid 38496401)
4. N Dora J Ou R Kucerova I Parisi JD West JM Collinson 2008 PAX6 dosage effects on corneal development, growth, and wound healing Dev Dyn 237 1295 1306 1:CAS:528:DC%2BD1cXntFOktb4%3D 10.1002/dvdy.21528 18386822 (Pubitemid 351668814)
5. N Dushku TW Reid 1994 Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells Curr Eye Res 13 473 481 1:STN:280:DyaK2M%2FgvVyqtA%3D%3D 10.3109/02713689408999878 7924411
6. N Dushku MK John GS Schultz TW Reid 2001 Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells Arch Ophthalmol 119 695 706 1:STN:280:DC%2BD3M3mslWisg%3D%3D 11346397
7. Y Garfias VM Bautista-De Lucio C García A Nava L Villalvazo MC Jiménez-Martínez 2009 Study of the expression of CD30 in pterygia compared to healthy conjunctivas Mol Vis 15 2068 2073 1:CAS:528: DC%2BD1MXhtlarsrnM 19862340
8. JC Grindley DR Davidson RE Hill 1995 The role of Pax-6 in eye and nasal development Development 121 1433 1442 1:CAS:528:DyaK2MXls1ajs7g%3D 7789273
9. LW Hirst 2003 The treatment of pterygium Surv Ophthalmol 48 145 180 10.1016/S0039-6257(02)00463-0 12686302 (Pubitemid 36398572)
10. S Kase M Osaki I Sato S Takahashi K Nakanishi K Yoshida H Ito S Ohno 2007 Immunolocalisation of E-cadherin and beta-catenin in human pterygium Br J Ophthalmol 91 1209 1212 10.1136/bjo.2007.115709 17360734 (Pubitemid 47344900)
11. S Kase S Takahashi I Sato K Nakanishi K Yoshida S Ohno 2007 Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium Br J Ophthalmol 91 958 961 10.1136/bjo.2006.110387 17179165 (Pubitemid 47013113)
12. LS Kwok MT Coroneo 1994 A model for pterygium formation Cornea 13 219 224 1:STN:280:DyaK2czgs12isg%3D%3D 10.1097/00003226-199405000-00005 8033571
13. GA Lee LW Hirst M Sheehan 1994 Knowledge of sunlight effects on the eyes and protective behaviors in the general community Ophthalmic Epidemiol 1 67 84 1:STN:280:DyaK28zot1Omsg%3D%3D 10.3109/09286589409052363 8790614
14. DQ Li SB Lee Z Gunja-Smith Y Liu A Solomon D Meller SC Tseng 2001 Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts Arch Ophthalmol 119 71 80 1:CAS:528:DC%2BD3MXosleltw%3D%3D 11146729
15. W Li YT Chen Y Hayashida G Blanco A Kheirkah H He SY Chen CY Liu SC Tseng 2008 Down-regulation of Pax6 is associated with abnormal differentiation of corneal epithelial cells in severe ocular surface diseases J Pathol 214 114 122 1:CAS:528:DC%2BD1cXhtlyms70%3D 10.1002/path.2256 18027901
16. I Massova LP Kotra R Fridman S Mobashery 1998 Matrix metalloproteinases: structures, evolution, and diversification FASEB J 12 1075 1095 1:CAS:528:DyaK1cXlvFWnur4%3D 9737711
17. CJ Morrison GS Butler D Rodriguez CM Overall 2009 Matrix metalloproteinase proteomics: substrates, targets, and therapy Curr Opin Cell Biol 21 645 653 1:CAS:528:DC%2BD1MXhtFyqt7rI 10.1016/j.ceb.2009.06.006 19616423
18. T Ramaesh K Ramaesh MJ Collinson SA Chanas B Dhillon JD West 2005 Developmental and cellular factors underlying corneal epithelial dysgenesis in the Pax6± mouse model of aniridia Exp Eye Res 81 224 235 1:CAS:528:DC%2BD2MXntVGnsbo%3D 10.1016/j.exer.2005.02.002 16080917 (Pubitemid 41085811)
19. FS Ramalho C Maestri LN Ramalho A Ribeiro-Silva E Romao 2006 Expression of p63 and p16 in primary and recurrent pterygia Graefes Arch Clin Exp Ophthalmol 244 1310 1314 1:CAS:528:DC%2BD28XpvFamt78%3D 10.1007/s00417-006-0287- 5 16523297 (Pubitemid 44463470)
20. P Sakoonwatanyoo DT Tan DR Smith 2004 Expression of p63 in pterygium and normal conjunctiva Cornea 23 67 70 10.1097/00003226-200401000-00011 14701960 (Pubitemid 38031877)
21. Tsai YY, Chiang CC, Yeh KT, Lee H, Cheng YW (2010) TIMP 1 neutralizes MMPs activity to inhibit pterygium invasion. Invest Ophthalmol Vis Sci 51:3462-3467
22. J Westermarck VM Kahari 1999 Regulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 781 792 1:CAS:528:DyaK1MXjtFGksrs%3D 10224222
23. SF Yang CY Lin PY Yang SC Chao YZ Ye DN Hu 2009 Increased expression of gelatinase (MMP-2 and MMP-9) in pterygia and pterygium fibroblasts with disease progression and activation of protein kinase C Invest Ophthalmol Vis Sci 50 4588 4596 10.1167/iovs.08-3147 19420332